Menu
Back to Journals » OncoTargets and Therapy » Volume 14
Case report
Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,780 | Dovepress* | 4,025+ | 698 | 4,723 | |
| PubMed Central* | 755 | 162 | 917 | ||
| Totals | 4,780 | 860 | 5,640 | ||
| *Since 25 March 2021 | |||||
View citations on PubMed Central and Google Scholar